At the current price of 11.69, you should be able to buy the March 6.00/15.00 call spread for a debit of around 3.65 This would give you an effective share price of $9.65 which is $2 below the current price. Max profit would be $5.35
Keep your shares while doing this as a secondary strategy. Profits from this will lower your cost basis.
Hi, Tiger, you will be reward greatly ! Only by scientific view ( I majored in cell biology and biochemistry and did research on gene knock down ...) Report gene KD already give 0.5mg/kg dose of ARC-520 is equal to 0.25mg /kg dose of ALN-HBV. So PIIa 1mg/kg and 2mg/kg of dose of ARC-520 would be 2x and 4x dose of ALN 4 chimps dosings ..... go to Alnylam website to see poster of chimps result ... with single dose KD 0.7 HBsAg and multiply dose KD up to 2log ... I do not see any problem that ARWR PIIA would be around 0.5log and 1log around ... no mention mult- dose easily apply ... so just waiting for new.
You know and I know , CEO of ARWR knows the most ... if he say good at this sensitive timing and so you just need relax right !
You're not the only one. I was certain it was going to hover around 14/15, but I didn't expect shorts and TheStreet to beat it down this bad. I'm confident it'll shoot back up, even if its from a hype-pump. I'm waiting for 10's or low 11's. Might load up some more since results and qtr results are so near.